XML 77 R55.htm IDEA: XBRL DOCUMENT
v3.20.4

Shareholders' Equity (Deficit) (Details) - Schedule of outstanding options granted | 12 Months Ended
--- | ---
Dec. 31, 2020 $ / shares shares
Shareholders' Equity (Deficit) (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 433,852
Options exercisable | 276,789
March 2013 [Member] |
Shareholders' Equity (Deficit) (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 22,258
Average Exercise price per share (in Dollars per share) | $ / shares | $ 1.76
Options exercisable | 22,258
Exercisable | March 2023
October 2013 [Member] |
Shareholders' Equity (Deficit) (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 5,719
Average Exercise price per share (in Dollars per share) | $ / shares | $ 5.06
Options exercisable | 5,719
Exercisable | October 2023
June 2014 [Member] |
Shareholders' Equity (Deficit) (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 5,617
Average Exercise price per share (in Dollars per share) | $ / shares | $ 5.06
Options exercisable | 5,617
Exercisable | June 2024
September 2014 [Member] |
Shareholders' Equity (Deficit) (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 5,719
Average Exercise price per share (in Dollars per share) | $ / shares | $ 5.06
Options exercisable | 5,719
Exercisable | September 2024
April 2016 [Member] |
Shareholders' Equity (Deficit) (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 5,975
Average Exercise price per share (in Dollars per share) | $ / shares | $ 3.10
Options exercisable | 5,975
Exercisable | April 2026
December 2016 [Member] |
Shareholders' Equity (Deficit) (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 7,170
Average Exercise price per share (in Dollars per share) | $ / shares | $ 3.93
Options exercisable | 7,170
Exercisable | March 2023
June 2017 [Member] |
Shareholders' Equity (Deficit) (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 197,722
Average Exercise price per share (in Dollars per share) | $ / shares | $ 4.10
Options exercisable | 136,594
Exercisable | June 2027
August 2017 [Member] |
Shareholders' Equity (Deficit) (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 5,617
Average Exercise price per share (in Dollars per share) | $ / shares | $ 9.29
Options exercisable | 5,617
Exercisable | August 2027
November 2017 [Member] |
Shareholders' Equity (Deficit) (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 17,925
Average Exercise price per share (in Dollars per share) | $ / shares | $ 7.70
Options exercisable | 17,925
Exercisable | March 2027
August 2019 [Member] |
Shareholders' Equity (Deficit) (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 71,700
Average Exercise price per share (in Dollars per share) | $ / shares | $ 8.18
Options exercisable | 64,195
Exercisable | August 2029
June 2020 [Member] |
Shareholders' Equity (Deficit) (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 88,430
Average Exercise price per share (in Dollars per share) | $ / shares | $ 6.62
Exercisable | June 2030

X
- References No definition available. + Details
Name: | pypd_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpiration
Namespace Prefix: | pypd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pypd_ShareholdersEquityDeficitDetailsScheduleofoutstandingoptionsgrantedLineItems
Namespace Prefix: | pypd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(iii) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_MarchTwoThousandThirteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_OctoberTwoThousandThirteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_JuneTwoThousandFourteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_SeptemberTwoThousandFourteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_AprilTwoThousandSixteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_DecemberTwoThousandSixteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_JuneTwoThousandSeventeenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_AugustTwoThousandSeventeenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_NovemberTwoThousandSeventeenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_AugustTwoThousandNineteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_JuneTwoThousandTwentyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |